These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 20464256)

  • 1. [Biological, clinical and epidemiological aspects of latent tuberculosis].
    Barrios-Payán JA; Castañón-Arreola M; Flores-Valdez MA; Hernández-Pando R
    Salud Publica Mex; 2010; 52(1):70-8. PubMed ID: 20464256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The secret trumps, impelling the pathogenicity of tubercle bacilli.
    Cardona PJ; Ivanyi J
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():14-9. PubMed ID: 21420562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic plasticity between human and mycobacterial DNA: A review.
    Danjuma L; Ling MP; Hamat RA; Higuchi A; Alarfaj AA; Marlina ; Benelli G; Arulselvan P; Rajan M; Kumar Subbiah S
    Tuberculosis (Edinb); 2017 Dec; 107():38-47. PubMed ID: 29050770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Latent tuberculosis infection: what we know about its genetic control?
    Kondratieva T; Azhikina T; Nikonenko B; Kaprelyants A; Apt A
    Tuberculosis (Edinb); 2014 Sep; 94(5):462-8. PubMed ID: 25104213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncloaking an ancient adversary: Can pathogen biomarker elicitors play a role in confirming extrapulmonary TB and latent TB infection?
    Porter BW; Venkatappa TK
    Tuberculosis (Edinb); 2018 Dec; 113():30-37. PubMed ID: 30514511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focus on latent tuberculosis.
    The Lancet Respiratory Medicine
    Lancet Respir Med; 2016 Oct; 4(10):763. PubMed ID: 27707455
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug targets in dormant Mycobacterium tuberculosis: can the conquest against tuberculosis become a reality?
    Gupta VK; Kumar MM; Singh D; Bisht D; Sharma S
    Infect Dis (Lond); 2018 Feb; 50(2):81-94. PubMed ID: 28933243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Management of Latent Tuberculosis Infection.
    Muñoz L; Stagg HR; Abubakar I
    Cold Spring Harb Perspect Med; 2015 Jun; 5(11):. PubMed ID: 26054858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National position statement for the management of latent tuberculosis infection.
    Stock D;
    Commun Dis Intell Q Rep; 2017 Sep; 41(3):E204-E208. PubMed ID: 29720068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of latent tuberculosis infection.
    Vernon A
    Semin Respir Crit Care Med; 2013 Feb; 34(1):67-86. PubMed ID: 23460007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis elimination and the challenge of latent tuberculosis.
    Matteelli A; Sulis G; Capone S; D'Ambrosio L; Migliori GB; Getahun H
    Presse Med; 2017 Mar; 46(2 Pt 2):e13-e21. PubMed ID: 28279508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerability of rifampin monotherapy for latent tuberculosis infection in children.
    Daskalaki I; Byun J; Dogbey MC; Tolbert-Warren C; Watson BM
    Pediatr Infect Dis J; 2011 Nov; 30(11):1014-5. PubMed ID: 21997666
    [No Abstract]   [Full Text] [Related]  

  • 14. Latent tuberculosis infection (LTBI): a real host defence or a permanent threat?
    Sanduzzi A; Ponticiello A; Bocchino M; Perna F; Vatrella A
    Infez Med; 2016 Sep; 24(3):179-82. PubMed ID: 27668896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latent Tuberculosis Infection (LTBI) and Its Potential Targets: An Investigation into Dormant Phase Pathogens.
    Gutti G; Arya K; Singh SK
    Mini Rev Med Chem; 2019; 19(19):1627-1642. PubMed ID: 31241015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comments on the article "Biological, clinical and epidemiological aspects of latent tuberculosis" by Jorge A. Barrios Payán et al.].
    Hernández-Garduño E
    Salud Publica Mex; 2010; 52(5):383-4; author reply 384-5. PubMed ID: 21049670
    [No Abstract]   [Full Text] [Related]  

  • 17. The Mycobacterium tuberculosis mysB gene product is a functional equivalent of the Escherichia coli sigma factor, KatF.
    Mulder NJ; Powles RE; Zappe H; Steyn LM
    Gene; 1999 Nov; 240(2):361-70. PubMed ID: 10580156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latent Mycobacterium tuberculosis infection.
    Getahun H; Matteelli A; Chaisson RE; Raviglione M
    N Engl J Med; 2015 May; 372(22):2127-35. PubMed ID: 26017823
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistent and dormant tubercle bacilli and latent tuberculosis.
    Zhang Y
    Front Biosci; 2004 May; 9():1136-56. PubMed ID: 14977534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.
    LoBue PA; Mermin JH
    Lancet Infect Dis; 2017 Oct; 17(10):e327-e333. PubMed ID: 28495525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.